![URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19](https://news.europawire.eu/wp-content/uploads/2021/02/URSAPHARM-Arzneimittel-and-CEBINA-announce-partnership-to-repurpose-the-antihistamine-azelastine-to-combat-COVID-19-144x144.png)
(PRESS RELEASE) SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EuropaWire/ — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts … Read the full press release